What is the management approach for a patient with 2nd degree atrioventricular (AV) block, with or without symptoms such as dizziness, lightheadedness, or shortness of breath?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Second-Degree Atrioventricular Block

Immediate Distinction: Mobitz Type I vs. Type II

The critical first step is distinguishing Mobitz Type I (Wenckebach) from Mobitz Type II, as this fundamentally determines management—Mobitz Type II requires permanent pacemaker implantation regardless of symptoms, while Mobitz Type I typically does not unless symptomatic or infranodal. 1

Mobitz Type I (Wenckebach) Characteristics:

  • Progressive PR interval prolongation before a blocked P wave, with PR shortening after the blocked beat 2, 1
  • Usually occurs at the AV node level, especially with narrow QRS 2
  • Can be present in healthy, well-trained endurance athletes and during sleep 1
  • Generally benign course in patients without organic heart disease 3

Mobitz Type II Characteristics:

  • Constant PR intervals before and after blocked P waves without progressive prolongation 2, 1
  • Almost always infranodal (His-Purkinje system), particularly with wide QRS 2, 4
  • Always considered abnormal and requires evaluation regardless of symptoms 1
  • High risk of progression to complete heart block 2, 4

Critical Diagnostic Pitfall:

2:1 AV block cannot be classified as Type I or Type II based on ECG alone—stress testing or electrophysiology studies are needed to distinguish 2:1 Wenckebach physiology from true Mobitz Type II. 1, 4 The coexistence of obvious Type I patterns elsewhere in the same recording (e.g., Holter) effectively rules out Type II block. 4


Management Algorithm for Mobitz Type II

Permanent pacemaker implantation is indicated for ALL patients with acquired Mobitz Type II second-degree AV block not attributable to reversible causes, regardless of symptoms. 2, 1

Class I Indications (Must Implant):

  • Any Mobitz Type II block with symptomatic bradycardia 2
  • Mobitz Type II block even when asymptomatic, as progression to complete heart block is common and sudden 2, 1
  • Patients with neuromuscular diseases (myotonic dystrophy, Kearns-Sayre syndrome, Erb dystrophy) with any second-degree AV block 2, 1

Rationale:

Type II block indicates diffuse conduction system disease with compromised prognosis and frequent symptoms. 2 Progression to third-degree AV block is common and sudden, making prophylactic pacing essential even in asymptomatic patients. 2


Management Algorithm for Mobitz Type I (Wenckebach)

Symptomatic Patients:

Permanent pacing is indicated when symptoms (dizziness, lightheadedness, shortness of breath, syncope) are clearly attributable to the AV block. 2, 1

Asymptomatic Patients—Risk Stratification Required:

High-Risk Features Requiring Pacemaker:

  • Wide QRS complex: Electrophysiological study is required to determine block level; if intra- or infra-Hisian, pacing is indicated 2
  • Coexisting bundle branch block: Increases risk of progression to higher-degree block 1
  • Shortest PR interval ≥300 ms: Warrants 24-hour ECG monitoring and consideration for pacing 1
  • Diurnal occurrence: Some evidence suggests pacemaker implantation improves survival in elderly patients with daytime Type I block, even without symptoms 2

Low-Risk Features (Observation Acceptable):

  • Narrow QRS complex with normal PR intervals (indicates AV nodal block) 2
  • Nocturnal occurrence in young, healthy individuals or athletes 2, 1
  • No organic heart disease 3

Special Diagnostic Considerations:

  • Exercise-induced AV block: If not secondary to myocardial ischemia, indicates His-Purkinje disease with poor prognosis—pacing is indicated 2
  • Exertional symptoms with resting Type I block: Exercise treadmill testing is reasonable to determine potential benefit from permanent pacing 1

Evaluation Protocol

Initial Assessment:

  • ECG analysis: QRS width, PR interval pattern, presence of bundle branch block 2, 1
  • Echocardiogram: Assess for structural heart disease 1
  • History: Age, underlying cardiac disease, medication review (AV nodal blocking agents), symptoms correlation 2, 1

When Electrophysiological Study is Indicated (Class I):

  • Symptomatic patients (syncope/near-syncope) where His-Purkinje block is suspected but not established on ECG 2
  • Type I block with wide QRS to determine if block is infranodal 2
  • Unclear 2:1 AV block to distinguish nodal from infranodal block 1

When Electrophysiological Study is NOT Needed (Class III):

  • Symptoms and presence of AV block are already correlated by electrocardiography 2
  • Asymptomatic patients with transient AV block associated with sinus slowing (e.g., nocturnal Type I block) 2

Special Clinical Contexts

Acute Myocardial Infarction:

  • Inferior MI with Type I block: Usually AV nodal, often benign; atropine may be used for symptomatic bradycardia 2
  • Type II block or new bifascicular block in MI: High risk—temporary pacing indicated, followed by permanent pacing if block persists 2
  • Mobitz Type II has NOT been reported in inferior MI—apparent Type II patterns in this setting are likely misdiagnosed Type I 4

Perioperative Management:

Prophylactic temporary pacemaker should be implanted preoperatively in patients with 2:1 AV block even without symptoms, as progression to complete heart block can occur with anesthesia induction. 5 This case report demonstrates conversion from asymptomatic 2:1 block to complete heart block immediately following general anesthesia induction. 5

Reversible Causes to Exclude:

  • Drug toxicity (beta-blockers, calcium channel blockers, digoxin, amiodarone) 6
  • Hyperkalemia 7
  • Sleep apnea (nocturnal block without symptoms does not require pacing) 2
  • Vagally mediated block (simultaneous sinus slowing suggests benign vagal surge) 1, 4

Critical Pitfalls to Avoid

  1. Do NOT assume narrow QRS Type I block is always benign: 60-70% of Type I blocks with bundle branch block are infranodal and require pacing 4

  2. Do NOT diagnose Type II block if:

    • The first post-block P wave shows a shortened PR interval 4
    • Sinus slowing accompanies the block (suggests vagal surge) 4
    • The P wave after the block is not clearly discernible 4
  3. Do NOT miss concealed His bundle or ventricular extrasystoles: These can mimic both Type I and Type II block (pseudo-AV block) and may be amenable to catheter ablation rather than pacing 2, 8, 4

  4. Do NOT delay pacing in Mobitz Type II: Progression to complete heart block is unpredictable and can be sudden 2


Prognosis

  • Type I block without organic heart disease: Benign course; only 1 patient in 19 required pacing over mean 1395-day follow-up 3
  • Type I block with organic heart disease: Poor prognosis related to severity of underlying cardiac disease, not the block itself 2, 3
  • Type II block (all infranodal blocks): Poor prognosis with frequent progression to higher-degree block and symptoms; untreated chronic infranodal block has poor outcomes 2

References

Guideline

Evaluation and Management of Mobitz I and Mobitz II AV Block

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Second-degree atrioventricular block revisited.

Herzschrittmachertherapie & Elektrophysiologie, 2012

Research

Second-degree atrioventricular block: Mobitz type II.

The Journal of emergency medicine, 1993

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.